Evidence map›Paper›PMID 39064646›Full record

Trial reportNutrients2024

Antiaging, Brightening, and Antioxidant Efficacy of Fermented Bilberry Extract (

Vincenzo Nobile, Stéphanie Dudonné, Catherine Kern, Gloria Roveda, Christine Garcia

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Nutrients, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Trial
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Vincenzo NobileR&D Department, Complife Italia S.r.l., 27028 San Martino Siccomario, Italy.ORCID 0000-0001-9147-302X
Stéphanie DudonnéSeppic Research and Innovation, 92250 La Garenne Colombes, France.ORCID 0000-0001-6581-4070
Catherine KernSeppic Research and Innovation, 92250 La Garenne Colombes, France.ORCID 0009-0003-2028-360X
Gloria RovedaClinical Trial Department, Complife Italia S.r.l., 27028 San Martino Siccomario, Italy.
Christine GarciaSeppic Research and Innovation, 92250 La Garenne Colombes, France.

Funding

Seppic Research and Innovation n/a
6 · The paper itself

Abstract

Strategies for successful aging, including the use of food supplements, are part of the approach to support skin youthfulness. To demonstrate the efficacy of fermented bilberry extract (FBE) against skin aging and uneven complexion, a clinical trial was carried out on 66 subjects with visible "crow's feet" wrinkles, mild-to-moderate skin slackness, and uneven skin tone. The wrinkle depth, skin smoothness (Ra) and roughness (Rz), skin firmness (R0) and elasticity (R2), skin coloration (ITA°), and skin antioxidant capacity were measured before and after 28 (D28), 56 (D56), and 84 (D84) days of product use (either FBE or a placebo). These parameters were also integrated with a clinical evaluation, carried out by a dermatologist, and a self-assessment questionnaire to align the measured efficacy with the visual or perceived efficacy. At D84, the wrinkle depth had decreased by 10.6%, Ra had improved by 7.9%, Rz had decreased by 7.3%, R0 had improved by 13.3%, R2 had improved by 12.4%, and skin antioxidant capacity had increased by 20.8%. ITA° increased by 20.8% and was accompanied by a decrease in the skin's redness component by 16.8% and an increase in the lightness component by 2.2%. The variation of all the above-mentioned parameters was statistically significant between the FBE and PL groups. Our findings demonstrate the efficacy of FBE in improving skin aging and complexion evenness.

Indexed as

AntioxidantsPlant ExtractsSkin AgingVaccinium myrtillusAdultAgedAnthocyaninsDietary SupplementsDouble-Blind MethodFemaleFermentationHumansMaleMiddle AgedSkinSkin PigmentationAnthocyaninsAntioxidantsPlant ExtractsVaccinium myrtillus extractbilberry extractclinical trialnutricosmeticspolyphenolsskin agingskin complexion

Identifiers

PMID39064646
PMCPMC11280171

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.